pI: 5.8441 |
Length (AA): 1038 |
MW (Da): 114404 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 399 | 1ngv (A) | 6 | 526 | 19.00 | 0 | 1 | 0.16 | -0.25 |
429 | 966 | 1y8q (B) | 7 | 473 | 30.00 | 0 | 1 | 0.59 | 0.49 |
595 | 851 | 1z7l (A) | 629 | 889 | 42.00 | 0 | 1 | 0.64 | -1.12 |
5 | 1035 | 5l6h (A) | 13 | 1024 | 38.00 | 0 | 1 | 1.38186 | -0.1 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127070)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G30110 | ubiquitin-activating enzyme E1 1 |
Arabidopsis thaliana | AT5G06460 | ubiquitin-activating enzyme E1 2 |
Babesia bovis | BBOV_II007710 | ubiquitin-activating enzyme E1, putative |
Brugia malayi | Bm1_50525 | ube1-prov protein |
Candida albicans | CaO19.7438 | ubiquitin-activating enzyme |
Caenorhabditis elegans | CELE_C47E12.5 | Protein UBA-1, isoform B |
Cryptosporidium hominis | Chro.40260 | ubiquitin-activating enzyme e1 |
Cryptosporidium parvum | cgd4_2300 | ubiquitin-activating enzyme E1 (UBA) |
Dictyostelium discoideum | DDB_G0270272 | ubiquitin activating enzyme E1 |
Dictyostelium discoideum | DDB_G0277047 | hypothetical protein |
Drosophila melanogaster | Dmel_CG1782 | Ubiquitin activating enzyme 1 |
Echinococcus granulosus | EgrG_000491100 | ubiquitin modifier activating enzyme 6 |
Echinococcus granulosus | EgrG_000711500 | ubiquitin modifier activating enzyme 1 |
Entamoeba histolytica | EHI_038690 | ubiquitin-activating enzyme E1 1, putative |
Entamoeba histolytica | EHI_020270 | ubiquitin-activating enzyme, putative |
Echinococcus multilocularis | EmuJ_000491100 | ubiquitin modifier activating enzyme 6 |
Echinococcus multilocularis | EmuJ_000711500 | ubiquitin modifier activating enzyme 1 |
Giardia lamblia | GL50803_10661 | Ubiquitin-conjugating enzyme E1 |
Homo sapiens | ENSG00000130985 | ubiquitin-like modifier activating enzyme 1 |
Homo sapiens | ENSG00000182179 | ubiquitin-like modifier activating enzyme 7 |
Homo sapiens | 55236 | ubiquitin-like modifier activating enzyme 6 |
Leishmania braziliensis | LbrM.23.0700 | ubiquitin-activating enzyme e1, putative |
Leishmania donovani | LdBPK_230710.1 | ubiquitin-activating enzyme E1, putative |
Leishmania infantum | LinJ.23.0710 | ubiquitin-activating enzyme e1, putative |
Leishmania major | LmjF.23.0550 | ubiquitin-activating enzyme e1, putative |
Leishmania mexicana | LmxM.23.0550 | ubiquitin-activating enzyme e1, putative |
Loa Loa (eye worm) | LOAG_03774 | ube1-prov protein |
Mus musculus | ENSMUSG00000001924 | ubiquitin-like modifier activating enzyme 1 |
Mus musculus | ENSMUSG00000032596 | ubiquitin-like modifier activating enzyme 7 |
Mus musculus | ENSMUSG00000035898 | ubiquitin-like modifier activating enzyme 6 |
Mus musculus | ENSMUSG00000069053 | ubiquitin-activating enzyme, Chr Y |
Neospora caninum | NCLIV_042500 | Ubiquitin-activating enzyme E1, related |
Oryza sativa | 4344380 | Os07g0692900 |
Oryza sativa | 4332529 | Os03g0294900 |
Oryza sativa | 9267214 | Os03g0613100 |
Oryza sativa | 4349557 | Os11g0106400 |
Oryza sativa | 9271171 | Os12g0105950 |
Plasmodium berghei | PBANKA_1440700 | ubiquitin-activating enzyme E1, putative |
Plasmodium falciparum | PF3D7_1225800 | ubiquitin-activating enzyme E1 |
Plasmodium knowlesi | PKNH_1445200 | ubiquitin-activating enzyme E1, putative |
Plasmodium yoelii | PY01879 | Uba1 gene product-related |
Saccharomyces cerevisiae | YKL210W | E1 ubiquitin-activating protein UBA1 |
Schistosoma japonicum | Sjp_0065510 | ko:K03178 ubiquitin-activating enzyme E1, putative |
Schistosoma japonicum | Sjp_0063670 | Ubiquitin-like modifier-activating enzyme 6, putative |
Schistosoma mansoni | Smp_162630.2 | ubiquitin-activating enzyme E1 |
Schmidtea mediterranea | mk4.026123.02 | |
Schmidtea mediterranea | mk4.000467.00 | Putative ubiquitin-activating enzyme e1 |
Schmidtea mediterranea | mk4.000925.11 | Putative ubiquitin-activating enzyme e1 |
Schmidtea mediterranea | mk4.026123.00 | Putative clathrin coat associated protein ap-50 |
Schmidtea mediterranea | mk4.018920.02 | Putative clathrin coat associated protein ap-50 |
Schmidtea mediterranea | mk4.000102.06 | Ubiquitin-like modifier-activating enzyme 6 |
Schmidtea mediterranea | mk4.018920.01 | |
Schmidtea mediterranea | mk4.018920.00 | |
Schmidtea mediterranea | mk4.004540.00 | |
Trypanosoma brucei gambiense | Tbg972.8.2140 | ubiquitin-activating enzyme e1, putative |
Trypanosoma brucei | Tb927.8.2640 | ubiquitin-activating enzyme E1, putative |
Trypanosoma congolense | TcIL3000_8_2480 | ubiquitin-activating enzyme E1, putative |
Trypanosoma cruzi | TcCLB.508043.30 | ubiquitin-activating enzyme E1, putative |
Trypanosoma cruzi | TcCLB.504427.250 | ubiquitin-activating enzyme E1, putative |
Theileria parva | TP02_0689 | ubiquitin-protein ligase, putative |
Trichomonas vaginalis | TVAG_300590 | ubiquitin-activating enzyme E1, putative |
Trichomonas vaginalis | TVAG_006110 | ubiquitin-activating enzyme E1, putative |
Trichomonas vaginalis | TVAG_090800 | ubiquitin-activating enzyme E1c, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.2640 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2640 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2640 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.8.2640 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C47E12.5 | Caenorhabditis elegans | adult lethal | wormbase |
CELE_C47E12.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C47E12.5 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C47E12.5 | Caenorhabditis elegans | sterile | wormbase |
YKL210W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1440700 | Plasmodium berghei | Dispensable | plasmo |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ubiquitin-like modifier activating enzyme 1 | Compounds | References |
Homo sapiens | ubiquitin-like modifier activating enzyme 7 | Compounds | References |
Homo sapiens | ubiquitin-like modifier activating enzyme 6 | Compounds | References |
4 literature references were collected for this gene.